tradingkey.logo

Prenetics Global Ltd

PRENW
View Detailed Chart

0.033USD

+0.000+0.31%
Market hours ETQuotes delayed by 15 min
0.00Market Cap
--P/E TTM

Prenetics Global Ltd

0.033

+0.000+0.31%
Intraday
1m
30m
1h
D
W
M
D

Today

+0.31%

5 Days

-14.14%

1 Month

-23.54%

6 Months

+228.00%

Year to Date

+320.51%

1 Year

+228.00%

View Detailed Chart

Agency Rating

No Data

Indicators

The Indicators feature provides value and direction analysis for various instruments under a selection of technical indicators, together with a technical summary.

This feature includes nine of the commonly used technical indicators: MACD, RSI, KDJ, StochRSI, ATR, CCI, WR, TRIX and MA. You may also adjust the timeframe depending on your needs.

Please note that technical analysis is only part of investment reference, and there is no absolute standard for using numerical values to assess direction. The results are for reference only, and we are not responsible for the accuracy of the indicator calculations and summaries.

1m
15m
30m
1h
D
W
M
1m
15m
30m
D
Buy
Sell(3)
Neutral(4)
Buy(6)
Indicators
Sell(1)
Neutral(4)
Buy(2)
Indicators
Value
Direction
MACD(12,26,9)
-0.004
Neutral
RSI(14)
51.128
Neutral
STOCH(KDJ)(9,3,3)
56.788
Neutral
ATR(14)
0.014
High Vlolatility
CCI(14)
20.201
Neutral
Williams %R
24.714
Buy
TRIX(12,20)
-0.033
Sell
StochRSI(14)
100.000
Buy
Moving Average
Sell(2)
Neutral(0)
Buy(4)
Indicators
Value
Direction
MA5
0.026
Buy
MA10
0.033
Sell
MA20
0.033
Sell
MA50
0.026
Buy
MA100
0.017
Buy
MA200
0.013
Buy

News

More news coming soon, stay tuned...

Financial Indicators

EPS

No Data

Total revenue

No Data

Company

Prenetics Global Ltd is a company principally engaged in the provision of diagnostic and preventive products and services. The Company operates its business through two segments. The Diagnostics segment is mainly engaged in the sale of precision oncology testing services. The Prevention segment is mainly engaged in the design and sale of genetics testing, including update services, and stool-based deoxyribonucleic acid (DNA) tests for early colorectal cancer screening. The Company's products and services include CircleDNA, ACTOnco, ACTHRD and other products. The in-house developed consumer genetic testing product, CircleDNA, offers comprehensive DNA tests capitalizing on in-house developed testing algorithm. ACTOnco is a comprehensive cancer test used to guide treatment selection for major solid tumors. ACTHRD is a test for the homologous recombination deficiency status of cancer patients. The Company is also engaged in consumer health products by a new health and wellness brand IM8.
Ticker SymbolPRENW
CompanyPrenetics Global Ltd
CEOMr. Joel Neoh
Websitehttps://ir.prenetics.com/
KeyAI